Medicare Wheelchair/Scooter Approval: Step-by-Step

Looking for fast, clear answers on Medicare wheelchair approval and scooter approval? Here’s the exact path our Navigators run so you get the right device, approved the first time.

The 7 essential steps

1) Confirm medical need in the home (MRADLs)

• Your clinician documents which in‑home activities (MRADLs) are unsafe, impossible, or unreasonably time‑consuming—and why lower‑level aids (cane/walker) don’t work. See CMS’s MAE policy (NCD 280.3) and related LCDs. Medicare.gov DME basics and NCD 280.3 summary.

2) Complete a face‑to‑face visit within 6 months

• For PMDs on the Required List, a qualifying F2F exam and complete Standard Written Order (SWO) must be in place prior to delivery. CMS DMEPOS order & F2F requirements.

3) Choose the right device category

• Scooter (POV) vs. Power Wheelchair (PWC) depends on ability to transfer, operate a tiller (POV), trunk control, cognition/vision, and home layout. Many higher‑group PWCs require PT/OT seating eval and a RESNA‑certified ATP. PMD LCD L33789.

4) Assemble a complete documentation packet

• F2F note, SWO/WOPD, home assessment, PT/OT eval (when indicated), ATP notes (for CRT/Group 3+), trials/contraindications to lower‑level aids, and device‑specific clinical rationale. See our packet checklist below and CMS MLN compliance tips: Manual wheelchairs, Walkers, Wheelchair options/accessories.

5) Prior authorization (when required)

• Many PMD bases require PA; as of Jan 1, 2025, CMS must decide within ≤7 calendar days (standard) or 2 business days (expedited when delay risks health/function). Replacement PMDs also require PA. CMS PA program and CGS PA HCPCS list.

6) Use a Medicare‑enrolled supplier that accepts assignment

• This helps avoid unexpected costs; MA plans may add network rules and PA. Medicare.gov: walkers coverage and supplier participation.

7) Delivery, training, and follow‑up

• Ensure fit/programming, capture delivery docs, and schedule follow‑ups. Manage repairs vs. replacement using reasonable useful lifetime (RUL) rules. Noridian RUL clarification.

Quick approval checklist

• MRADLs documented in the home with specific barriers

• Trials/contraindications of lower‑level aids

• F2F within 6 months and complete SWO/WOPD (when required)

• Device‑specific criteria met (e.g., tiller operation for scooters)

• Specialty seating eval and ATP involvement for CRT/Group 3+ when indicated

• Supplier accepts assignment; PA submitted when required

• Home assessment supports safe use and maneuverability

FAQ: Medicare Wheelchairs and Scooters

• How long does Medicare PMD prior auth take? As of Jan 1, 2025, ≤7 calendar days (standard) or 2 business days (expedited). CMS timeframe update.

• Do I always need a face‑to‑face visit? For PMDs on CMS’s Required List, yes—within 6 months prior to order; SWO/WOPD must be complete before delivery. DMEPOS order & F2F requirements.

• Scooter vs. Power Wheelchair—what’s the difference for coverage? Scooters (POVs) require ability to transfer and steer a tiller with adequate trunk control and compatible home layout. PWCs are indicated when POV criteria aren’t met or needs are more complex. PMD LCD L33789.

• What will I pay? Under Part B, after deductible, 20% coinsurance applies when the supplier accepts assignment. MA plan cost‑sharing and network rules vary. Medicare.gov DME basics.

• Are seat elevation and other accessories covered? Yes, when criteria are met (e.g., seat elevation on eligible PWCs for transfers/reach/MRADLs). See CMS/ACL/AAPM&R sources and MLN accessories guidance in the Accessory coverage section below.

• Repairs or replacement? DME has a typical 5‑year RUL; Medicare covers repairs, but excessive repair costs may indicate replacement. Noridian RUL clarification.

Structured data (How

To + FAQ)

{
 "@context": "https://schema.org",
 "@graph": [
 {
 "@type": "HowTo",
 "name": "Medicare Wheelchair/Scooter Approval: Step-by-Step",
 "description": "A seven-step process to secure Medicare approval for a wheelchair, power wheelchair, or scooter (POV), including documentation, F2F exam, SWO/WOPD, and prior authorization.",
 "step": [
 {"@type": "HowToStep", "name": "Document in-home need (MRADLs)", "text": "Clinician notes which MRADLs are unsafe/impossible and why lower-level aids fail (per NCD 280.3/LCDs)."},
 {"@type": "HowToStep", "name": "Complete face-to-face exam", "text": "For Required List PMDs, F2F within 6 months and SWO/WOPD before delivery per CMS DMEPOS rules."},
 {"@type": "HowToStep", "name": "Select device category", "text": "Scooter vs PWC based on transfer ability, tiller operation, posture, cognition/vision, home layout; PT/OT + ATP may be required for CRT."},
 {"@type": "HowToStep", "name": "Assemble packet", "text": "Include F2F notes, SWO/WOPD, home assessment, PT/OT eval, ATP notes (if CRT), trials/contraindications, device rationale."},
 {"@type": "HowToStep", "name": "Submit prior authorization", "text": "Many PMD bases require PA; CMS decision ≤7 days standard or 2 business days expedited starting 2025."},
 {"@type": "HowToStep", "name": "Use enrolled supplier", "text": "Choose a Medicare-enrolled supplier accepting assignment; MA plans may require in-network providers."},
 {"@type": "HowToStep", "name": "Delivery and follow-up", "text": "Fit/program device, complete delivery docs, schedule follow-ups; manage repairs vs replacement using RUL."}
 ]
 },
 {
 "@type": "FAQPage",
 "mainEntity": [
 {"@type": "Question", "name": "How long does Medicare prior authorization take?", "acceptedAnswer": {"@type": "Answer", "text": "As of Jan 1, 2025, CMS must decide within ≤7 calendar days (standard) or 2 business days (expedited)."}},
 {"@type": "Question", "name": "Do I need a face-to-face visit?", "acceptedAnswer": {"@type": "Answer", "text": "Yes for PMDs on the Required List; F2F must occur within 6 months before order and SWO/WOPD must be completed prior to delivery."}},
 {"@type": "Question", "name": "Scooter vs power wheelchair—how does Medicare decide?", "acceptedAnswer": {"@type": "Answer", "text": "Scooters require transfer ability, tiller operation, and trunk control; PWCs are indicated when POV criteria aren’t met or needs are more complex."}},
 {"@type": "Question", "name": "What will I pay under Medicare?", "acceptedAnswer": {"@type": "Answer", "text": "After the Part B deductible, 20% coinsurance applies if the supplier accepts assignment; MA plans have their own cost-sharing and network rules."}},
 {"@type": "Question", "name": "Are accessories like seat elevation covered?", "acceptedAnswer": {"@type": "Answer", "text": "Yes when criteria are met (e.g., seat elevation on eligible PWCs for transfers/reach/MRADLs), per CMS national coverage and MLN guidance."}},
 {"@type": "Question", "name": "Repairs vs replacement?", "acceptedAnswer": {"@type": "Answer", "text": "DME typically has a 5-year reasonable useful lifetime; Medicare covers necessary repairs, but excessive costs may indicate replacement."}}
 ]
 }
 ]
}

Introduction

Aviator Health helps Medicare beneficiaries secure the right mobility equipment and accessories with minimal friction by combining licensed Healthcare Navigators with AI-enabled workflows. Our Navigators manage medical‑necessity documentation, prior authorization (PA), supplier coordination, fitting, delivery, and follow‑up—typically at $0 out‑of‑pocket when covered by Medicare or Medicare Advantage (MA). See our mobility support pages for national mobility help, Florida, Georgia, and Texas. We provide whole‑person navigation across medical, behavioral, and social needs; learn more about Aviator Health.

Medicare rules that drive every decision

• Medicare covers Durable Medical Equipment (DME) when it is medically necessary for use in the home and can withstand repeated use (expected ≥3‑year durability). After Part B deductible, beneficiaries pay 20% coinsurance if the supplier accepts assignment. Some DME is purchased, some rented, and some allows choice. Medicare.gov DME overview.

• Mobility Assistive Equipment (MAE)—canes, walkers/rollators, manual wheelchairs, power wheelchairs (PWCs), and scooters (POVs)—is covered when a mobility limitation prevents, risks, or unreasonably delays mobility‑related activities of daily living (MRADLs) in the home. This standard comes from CMS’s national policy for MAE (NCD 280.3) and related LCDs. CMS NCD 280.3 summary via National Academies.

• Written orders and face‑to‑face (F2F) rules: CMS standardized the DMEPOS written order (SWO) and maintains Master/Required Lists for items that also need a F2F exam and/or WOPD (written order prior to delivery). For items on the Required List (which includes PMDs), the F2F must occur within 6 months before the order, and the complete order must be in place before delivery. CMNs/DIFs were discontinued 1/1/2023. CMS DMEPOS order & F2F requirements and MLN DMEPOS Quality Standards.

• Prior authorization (PA): Certain PMD bases require PA nationally; as of 2025, PMD accessories can be submitted with the base on a voluntary basis. CMS shortened standard review to no more than 7 calendar days starting January 1, 2025 (2 business days if expedited). Replacement PMDs on the Required List also require PA. CMS PA program, CGS replacement PMD PA, and CGS list of PA HCPCS.

• Reasonable useful lifetime (RUL) and repairs: DME typically has a 5‑year RUL; repairs are covered, but excessive accumulated repair costs may indicate the item should be replaced rather than repeatedly repaired. Noridian RUL clarification and HHS‑OIG report on wheelchair repairs within RUL.

• Supplier rules: To avoid unexpected costs, beneficiaries must use suppliers enrolled in Medicare who accept assignment; MA plans typically add network and prior‑auth rules. See Medicare.gov: walkers coverage and supplier participation.

What a medically necessary note must include (checklist we manage)

For mobility devices, CMS expects the clinical record to establish all of the following (Aviator drafts checklists and collaborates with clinicians to ensure completeness):

• MRADL impact in the home: exactly which MRADLs are prevented, unsafe, or unreasonably time‑consuming, and why. Cite specific barriers (e.g., “cannot reach bathroom within reasonable time due to dyspnea and balance loss”). Manual wheelchair LCD L33788 highlights and Walkers compliance tip referencing LCD L33791.

• Why lower‑level aids are insufficient: document trials/contraindications for cane/walker before stepping up to wheelchair/power mobility. Manual wheelchair compliance tip.

• Home suitability: maneuvering space and surfaces for the specific device (e.g., doorway widths for scooters with tiller). Power Mobility LCD L33789.

• Ability to use the device safely: cognition, vision, upper‑extremity function (or caregiver availability/willingness if self‑propulsion/operation isn’t possible). Manual wheelchairs and PMD LCD L33789.

• Device‑specific criteria: e.g., scooters require the ability to transfer, operate a tiller, and maintain posture; many Group 2+ or 4 power bases are non‑covered for “in‑home” needs; certain Group 3 PWCs require a specialty seating evaluation by PT/OT and involvement of a RESNA‑certified ATP. PMD LCD L33789 and Wheelchair options/accessories MLN tip referencing LCD L33792.

• Standard Written Order (SWO): beneficiary + item description (+ quantity), NPI/name, date, signature, prior to claim (and prior to delivery if on the Required WOPD list). CMS DMEPOS order requirements.

Prior authorization workflow we run end‑to‑end

• Determine if PA applies: Required PA list for PMD bases; voluntary accessory review; replacement PMDs need PA. We confirm correct HCPCS and jurisdictional rules. CMS PA program, CGS PMD PA timelines, and CGS list of PA HCPCS.

• Build a complete packet: F2F note(s), PT/OT specialty eval when required, SWO/WOPD, home assessment, relevant test results, seating/positioning rationale, supplier ATP involvement where required.

• Submit and track: As of January 1, 2025, standard PA decisions are due in ≤7 calendar days; expedited decisions in 2 business days where delay risks health/function. We monitor decision windows and trigger resubmissions as needed. CMS timeframe update.

• Communicate outcomes: We translate decision letters, coordinate addenda (e.g., alternative parts), and—if denied—prepare redetermination/appeal with corrected documentation.

Who is an ATP (RESNA)?

• An Assistive Technology Professional (ATP) is a credentialed specialist certified by RESNA whose role is to evaluate, configure, and help justify complex rehabilitation technology (CRT) such as higher‑group power wheelchairs and specialty seating/drive controls.

• For many Group 3+ power wheelchair (PWC) bases and advanced seating/positioning, DME MAC policy and supplier quality standards expect involvement of a RESNA‑certified ATP, typically in tandem with a PT/OT specialty seating evaluation. This ensures clinical need, configuration, and home use are appropriately documented. See PMD LCD L33789 and CMS MLN guidance on wheelchair options/accessories.

• What the ATP does: partners with the clinician and supplier to select components; documents trials/contraindications; confirms joystick/drive control and seating specifications (dimensions, angles, foam/gel types, support hardware); and attests to the final configuration used to meet in‑home MRADLs.

• Medicare Advantage plans and many suppliers explicitly require ATP participation or sign‑off for CRT; we route cases to complex‑rehab suppliers with RESNA‑certified ATPs when criteria indicate.

Step‑by‑step prior‑auth packet checklist (what we compile and QC)

1) Confirm item and PA applicability

• Identify the correct PMD base HCPCS and accessories; check jurisdiction (DME MAC) and whether PA is required for the base and optionally included for accessories. CMS PA program and CGS PA HCPCS list.

2) Face‑to‑Face (F2F) within 6 months

• F2F visit documentation addressing MRADLs, why lower‑level aids are insufficient, ability to use the device safely, and home suitability for the specific device. DMEPOS order & F2F requirements.

3) PT/OT specialty seating evaluation (when indicated)

• Required for many Group 3+ PWCs and advanced seating/positioning; includes posture, tone, pressure risk, transfer method, and trial results. PMD LCD L33789.

4) ATP involvement (CRT/Group 3+)

• Supplier’s RESNA‑certified ATP assessment and configuration notes; documentation of trials/contraindications and selected components; confirmation that configuration meets in‑home needs. Wheelchair options/accessories MLN tip.

5) Standard Written Order (SWO)/WOPD

• Complete SWO listing beneficiary, detailed item description(s) with quantities, NPI/name, date, and signature; WOPD if on the Required List (e.g., PMDs). DMEPOS order requirements.

6) Home assessment

• Measurements relevant to maneuverability and safety (door widths, turning radius, thresholds/surfaces, bathroom access), and notes on caregiver availability if applicable. PMD LCD L33789.

7) Lower‑level aid trials/contraindications

• Document why cane/walker/manual wheelchair or scooter is insufficient, unsafe, or not feasible, including trial outcomes or contraindications. Manual wheelchair tip/LCD L33788.

8) Device‑specific clinical rationale

• For scooters: ability to transfer, operate a tiller, maintain posture. For PWCs: justification of group level (e.g., neurologic/myopathic conditions for Group 3), need for specialty seating/controls. PMD LCD L33789.

9) Accessories list with clinical criteria

• Include seating/positioning (e.g., tilt/recline), leg rests, mounting hardware, batteries/chargers with clinical justification and any frequency/coverage limits. Wheelchair options/accessories MLN tip.

10) Supplier documents and quotes

• Supplier pricing/HCPCS lines aligned to configuration, ATP attestation (if applicable), and any plan‑specific forms; ensure dates/signatures meet WOPD timing where required.

11) Submission/tracking

• Submit as a complete packet; monitor the decision window (≤7 calendar days standard; 2 business days expedited) and respond promptly to any non‑affirmations. CMS timeframe update.

Example HCPCS by category (verify current lists before filing)

These examples help frame documentation; confirm active codes and PA status via your DME MAC and the CGS PA list.

If you’re unsure which codes apply, we’ll confirm jurisdictional policy and align documentation with NCD 280.3 and the relevant LCD before submission.

Selecting the right device (and proving it)

Below is a concise comparison of device types, common medical “fit” criteria, and documentation accents. We always individualize to the beneficiary’s condition, home, and goals.

Additional safety and training guidance for walkers vs rollators: Aviator’s walker vs. rollator guide.

Accessory coverage highlights (what’s newly covered and commonly missed)

• Power tilt/recline and related seating (E1002–E1010, E1012): Covered when PMD criteria are met, specialty seating eval is documented, and the patient meets risk/functional criteria (e.g., high pressure‑injury risk without functional weight shift, intermittent catheterization without independent transfers, or tone/spasticity management needs). CMS wheelchair options/accessories tip referencing LCD L33792.

• Power seat elevation systems on eligible power wheelchairs: Medicare created national coverage effective May 16, 2023 for beneficiaries who need seat elevation to transfer, reach, or perform MRADLs in the home (subject to safety evaluation). ACL announcement of CMS decision and AAPM&R summary.

• Elevating leg rests (ELRs) and recline: Covered when knee flexion is limited, there is significant LE edema, or the patient has a covered reclining back. CMS wheelchair options/accessories tip.

• Batteries/chargers: Coverage is limited by type and replacement frequency (e.g., lithium battery usual greatest frequency ~3 years; certain non‑sealed batteries not covered). CMS wheelchair options/accessories tip.

• New HCPCS for mounting hardware (effective 4/1/2025): CMS revised E1028 and added E1032/E1033 for swing‑away/retractable mounting hardware, improving coding clarity for joystick/drive‑control and headrest mounts. HomeCare Magazine report (industry summary of the DME MAC joint publication).

Supplier coordination and fitting

• We match patients to Medicare‑enrolled suppliers who accept assignment and, for MA members, are in‑network. We escalate to RESNA‑ATP complex‑rehab suppliers when required by policy (e.g., Group 3 PWC with power options). Wheelchair options/accessories tip.

• We coordinate equipment trials and precise fitting, including handle height and brake function for rollators and seating/drive‑control programming for PWCs (see Aviator’s walker vs. rollator safety/fitting guidance).

• We capture delivery documentation and training confirmation, schedule follow‑ups, and manage repairs versus replacement decisions in line with RUL policy. Noridian RUL clarification.

Medicare Advantage nuances (what to expect)

• MA plans must cover at least what Original Medicare covers, but may require prior authorization and restrict you to in‑network DME suppliers with plan‑specific cost‑shares. Always verify plan rules before ordering; we do this on each case. Medicare.gov DME basics and Medicare.gov walkers page on supplier participation.

• Supplemental “upgrades” may exist in some plans, but they are variable and often have limits; expectations should be anchored to Medicare’s medical‑necessity standards. For broader context on MA extras and variability, see the Medicare Rights Center’s analysis of supplemental benefits and consumer experience details. Medicare Rights Center policy brief.

How Aviator accelerates approvals and reduces denials

• Single point of contact: a dedicated Navigator coordinates clinicians, suppliers, and plans, joins telehealth visits as needed, and manages all forms and timelines. Aviator mobility, FL, GA, TX.

• Evidence‑first documentation: our intake templates mirror NCD 280.3 and LCD criteria (L33788, L33789, L33791, L33792), reducing “insufficient documentation” denials—the top driver of improper payments in these categories per CMS MLN compliance tips. Manual wheelchairs, Walkers, and Wheelchair options/accessories.

• PA clock management: we submit complete packets at once, monitor the 7‑day (standard) / 2‑day (expedited) decision windows, and immediately cure non‑affirmations with targeted addenda. CMS PA timeframe update.

• Appeals & replacements: when appropriate, we file timely redeterminations with precise references to NCD/LCD text, and we track repair spend against RUL to avoid waste and accelerate justified replacements. HHS‑OIG RUL report.

Quick answers

• Will Medicare cover a rollator? Yes, when MRADL‑based need is documented and you can use it safely in the home; ensure the supplier accepts assignment. CMS walkers page and Medicare.gov walkers. For safety and fit trade‑offs, see our walker vs. rollator guide.

• What about seat elevation on my power chair? As of May 16, 2023, Medicare covers it for eligible users when needed for transfers/reach/MRADLs in the home. ACL announcement.

• How long will PA take? For required items, CMS has set ≤7 calendar days (standard) and 2 business days (expedited) as of January 1, 2025. CMS PA timeframe update.

Get help

If you or a family member needs mobility equipment—or had a denial—Aviator Navigators can take the lift off your plate: coordinating clinicians, documentation, suppliers, authorizations, delivery, and appeals. Start with Aviator mobility support or learn why Healthcare Navigators are covered by Medicare.